P-232: Adverse event patterns and management with pomalidomide, dexamethasone, and daratumumab in patients with relapsed or refractory multiple myeloma: a safety analysis of the phase 2 MM-014 study
Titel:
P-232: Adverse event patterns and management with pomalidomide, dexamethasone, and daratumumab in patients with relapsed or refractory multiple myeloma: a safety analysis of the phase 2 MM-014 study
Auteur:
Bahlis, Nizar Schiller, Gary Samaras, Christy J. Sebag, Michael Berdeja, Jesus G. Ganguly, Siddhartha Matous, Jeffrey Song, Kevin Seet, Christopher Bar, Michael Quick, Donald Fonseca, Gustavo Reece, Donna E. Chung, Weiyuan Gentili, Christian Lee, Kim Siegel, David S.